Media headlines about Nanosphere (NASDAQ:NSPH) have been trending somewhat positive on Wednesday, according to Accern Sentiment Analysis. The research firm identifies positive and negative news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Nanosphere earned a media sentiment score of 0.03 on Accern’s scale. Accern also gave media coverage about the medical research company an impact score of 46.1554871581703 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

TRADEMARK VIOLATION WARNING: This report was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/11/08/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-nanosphere-nsph-share-price.html.

Nanosphere Company Profile

Nanosphere, Inc is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. The Verigene System includes a molecular diagnostics workstation that is a single use consumable for testing.

Insider Buying and Selling by Quarter for Nanosphere (NASDAQ:NSPH)

Receive News & Stock Ratings for Nanosphere Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanosphere Inc. and related stocks with our FREE daily email newsletter.